Abiopharma

🔍 Holmes Chad M (Executive)

Company: CRA INTERNATIONAL, INC. (CRAI)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 276 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,706.99 | transaction_form_type: 4 | Footnotes: F1
• Sold 6 shares of Common Stock at $154.55 per share (Direct)
  Date: 2026-04-29 | Code: D | equity_swap_involved: 0 | shares_owned_after: 46,701.00 | transaction_form_type: 4
• Sold 128 shares of Common Stock at $154.55 per share (Direct)
  Date: 2026-04-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 46,573.00 | transaction_form_type: 4
• Sold 828 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 551.98 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Holds 847 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 846.78 | Footnotes: F1, F3, F3
• Holds 1,579 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 1,579.00 | Footnotes: F1, F4, F4
• Holds 366 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 365.97 | Footnotes: F1, F5, F5
• Holds 642 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 641.74 | Footnotes: F1, F6, F6
• Holds 1,026 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: H | shares_owned_after: 1,026.27 | Footnotes: F1, F7, F7
• Holds 4,076 shares of Nonqualified Stock Option (right to buy) at $44.87 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2027-12-18 | Exercise: 2017-12-18 | shares_owned_after: 4,076.00 | Footnotes: F8
• Holds 4,425 shares of Non-qualified stock options (right to buy) at $47.45 per share (Derivative)
  Date: 2026-04-29 | Code: H | Expires: 2028-12-06 | Exercise: 2018-12-06 | shares_owned_after: 4,425.00 | Footnotes: F8

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock; vested RSUs are payable in the form of cash, shares of the Issuer's common stock or a combination thereof, except as otherwise indicated below. To the extent vested RSUs are paid in shares of the Issuer's common stock, such shares will be delivered to the reporting person as soon as possible after vesting, but in no event later than two and one-half months after the end of the year in which vesting occurs, subject to the collection of withholding taxes. Dividend equivalent rights accrue with respect to unvested RSUs in the form of additional RSUs ("Dividend Units") when and as dividends are paid on the Issuer's common stock, and Dividend Units vest on the same dates and in the same relative proportions as the RSUs on which they accrue.
• F2: The RSUs, which include an aggregate of 11.9758 Dividend Units, vest in two equal annual installments beginning on April 29, 2027.
• F3: The RSUs, which include an aggregate of 9.7766 Dividend Units, vest in four equal annual installments beginning on May 20, 2026.
• F4: The RSUs vest in four equal annual installments beginning on April 9, 2027.
• F5: The RSUs, which include an aggregate of 12.9695 Dividend Units, vest on April 11, 2027.
• F6: The RSUs, which include which include an aggregate of 22.7412 Dividend Units, vest on April 11, 2027.
• F7: The RSUs, which include an aggregate of 22.2730 Dividend Units, vest in two equal annual installments beginning on April 29, 2027.
• F8: Date indicated is date of grant. Option vests in four equal annual installments beginning on the first anniversary of the date of grant.